Role of ultrasound therapy using diclofenac gel in improvement of pain and mouth opening in patients with TM joint diseases.

COMPARATIVE ASSESSMENT OF THE EFFICACY OF PHONOPHORESIS USING DICLOFENAC GEL VERSUS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION IN TREATMENT OF TEMPOROMANDIBULAR JOINT DISORDERS - A RANDOMISED CONTROL TRIAL - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2026/03/105570

Enrollment

Registered

2026-03-06

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M248- Other specific joint derangements,not elsewhere classified Health Condition 2: M190- Primary osteoarthritis of other joints

Interventions

Intervention1: Phonophoresis with 1 MHz frequency, intensity 1.5w/cm2: Patient is made to sit in the upright position . The area of interest that is to be treated with ultrasound is cleaned with beta

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with disc derangement with reduction, Disc derangement without reduction and mayo-fascial pain dysfunction syndrome reporting with pain. 2. Age above 18 years and of either gender. 3. Patients willing to participate in the study and those who are willing to give consent for the same.

Exclusion criteria

Exclusion criteria: 1. Patents on pacemaker. 2. Pregnant patients 3. Patients having malignancy or infection in the vicinity of the treatment site . 4. Unco-operative patients. 5. Osteoarthritis 6. Rheumatoid arthritis 7. Ankylosis 8. Allergy to drugs 9. Patients having history of any other treatment one month before continued or discontinued.

Design outcomes

Primary

Measure	Time frame
1.To measure the improvement in symptoms of pain using VAS score in temporomandibular joint disorders in patients receiving Phonophoresis and transcutaneous nerve stimulation. 2. To check for improvement in mouth opening using Vernier caliper in patient receiving Phonophoresis and transcutaneous nerve stimulation. 3. Evaluation of clicking in patients receiving Phonophoresis and transcutaneous nerve stimulation. 4. To evaluate the reduction in deflection or deviation on mouth opening in patients receiving Phonophoresis and transcutaneous nerve stimulation. Timepoint: Twice weekly for four weeks and weekly for next two weeks	—

Measure

Time frame

1.To measure the improvement in symptoms of pain using VAS score in temporomandibular joint disorders in patients receiving Phonophoresis and transcutaneous nerve stimulation. 2. To check for improvement in mouth opening using Vernier caliper in patient receiving Phonophoresis and transcutaneous nerve stimulation. 3. Evaluation of clicking in patients receiving Phonophoresis and transcutaneous nerve stimulation. 4. To evaluate the reduction in deflection or deviation on mouth opening in patients receiving Phonophoresis and transcutaneous nerve stimulation. Timepoint: Twice weekly for four weeks and weekly for next two weeks

—

Secondary

Measure	Time frame
To compare the improvement in symptoms of pain, mouth opening, clicking, deflection or deviation in both the groups. Timepoint: Twice weekly for four weeks and weekly for next two weeks	—

Countries

India

Contacts

Public ContactDr LUCKY TIWARI

Government dental college and hospital , Mumbai

dreaswaran@yahoo.co.in9930831379

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026